In 2010, the US FDA approved the use of Lucentis intravitreal injections for macular edema; then in 2013, the National Institute for Health and Care Excellence in the UK also approved it to be used for the treatment of macular edema caused by diabetes and/or retinal vein occlusion.
Na
Na
Na
Na
Na
Na